Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target <i>Clostridioides difficile</i>

• Main Authors: Dahyun Kim (Author), Young-Rok Kim (Author), Hee-Jong Hwang (Author), Marco A. Ciufolini (Author), Jusuk Lee (Author), Hakyeong Lee (Author), Shyaka Clovis (Author), Sungji Jung (Author), Sang-Hun Oh (Author), Young-Jin Son (Author), Jin-Hwan Kwak (Author)
• Format: Book
• Published: MDPI AG, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The US Centers for Disease Control and Prevention (CDC) lists <i>Clostridioides difficile</i> as an urgent bacterial threat. Yet, only two drugs, vancomycin and fidaxomicin, are approved by the FDA for the treatment of <i>C. difficile</i> infections as of this writing, while...